Luis E Figuera
Overview
Explore the profile of Luis E Figuera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallegos-Arreola M, Garibaldi-Rios A, Gutierrez-Hurtado I, Zuniga-Gonzalez G, Figuera L, Gomez-Meda B, et al.
Genes (Basel)
. 2025 Jan;
15(12.
PMID: 39766795
Background/objectives: Colorectal cancer (CRC) is a multifactorial disease where the inflammatory state is crucial. This study analyzes the association of the IL-1RN (rs2234663) and IL-1β (rs1143627, rs16944) variants and IL-1β...
2.
Gallegos-Arreola M, Garibaldi-Rios A, Magana-Torres M, Figuera L, Gomez-Meda B, Zuniga-Gonzalez G, et al.
Diseases
. 2024 Nov;
12(11).
PMID: 39589950
This study investigated the association between the rs13306703 and rs8192288 variants of the superoxide dismutase 3 () gene and breast cancer (BC) in the Mexican population, conducting both genetic and...
3.
Zuno-Reyes A, Perez-Rubio K, Flores-Gonzalez M, Torres R, Dumois-Petersen S, Figuera L, et al.
Alzheimers Dement (Amst)
. 2024 Aug;
16(3):e12631.
PMID: 39170093
Introduction: We aimed to determine the effect of years of schooling (YoS) and age on the Mexican adaptation of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD-MX) scores...
4.
Garibaldi-Rios A, Figuera L, Zuniga-Gonzalez G, Gomez-Meda B, Garcia-Verdin P, Carrillo-Davila I, et al.
Diseases
. 2024 Jul;
12(7).
PMID: 39057123
Pancreatic cancer (PC) is highly lethal, with mutations in up to 95% of cases. miRNAs inversely correlate with expression, indicating potential as biomarkers. This study identified miRNAs targeting and their...
5.
Valdez-Gaxiola C, Rosales-Leycegui F, Gaxiola-Rubio A, Moreno-Ortiz J, Figuera L
Diseases
. 2024 Jun;
12(6).
PMID: 38920542
Early-onset Alzheimer's disease (EOAD), defined as Alzheimer's disease onset before 65 years of age, has been significantly less studied than the "classic" late-onset form (LOAD), although EOAD often presents with...
6.
Carrillo-Davila I, Garibaldi-Rios A, Figuera L, Gomez-Meda B, Zuniga-Gonzalez G, Puebla-Perez A, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540215
The aim of this study was to associate rs1966265 and rs351855 variants with colorectal cancer (CRC) in a Mexican population and to perform in silico analysis. Genomic DNA from 412...
7.
Valdez-Gaxiola C, Maciel-Cruz E, Hernandez-Pena R, Dumois-Petersen S, Rosales-Leycegui F, Gallegos-Arreola M, et al.
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958671
In Alzheimer's disease (AD), the age of onset (AoO) exhibits considerable variability, spanning from 40 to 90 years. Specifically, individuals diagnosed with AD and exhibiting symptoms prior to the age...
8.
Reyes-Dominguez Y, Figuera L, Brambila-Tapia A
Brain Sci
. 2023 Mar;
13(3).
PMID: 36979311
Early-onset Alzheimer's disease (EOAD) is an autosomal dominantly inherited disease, in which a founder effect has been described for A431E mutation in the gene, with most of the affected patients...
9.
Gallegos-Arreola M, Ramirez-Patino R, Sanchez-Lopez J, Zuniga-Gonzalez G, Figuera L, Delgado-Saucedo J, et al.
Curr Issues Mol Biol
. 2022 Nov;
44(11):5221-5233.
PMID: 36354667
The superoxide dismutase (SOD) is the principal antioxidant defense system in the body that is activated by a reactive oxygen species. Some variants of the SOD2 gene have been associated...
10.
Ruiz Ramirez A, Prado Montes de Oca E, Figuera L
Biology (Basel)
. 2022 Sep;
11(9).
PMID: 36138766
Even though a mutation in monogenic diseases leads to a "classic" manifestation, many disorders exhibit great clinical variability that could be due to modifying genes also called minor genes. Fabry...